Evaluating Stroke and Hemorrhage Risks Associated with Non–Vitamin K Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation - Top-Institutions - MDSpire

Evaluating Stroke and Hemorrhage Risks Associated with Non–Vitamin K Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation

  • By

  • Marie C. Bradley

  • Andrew L. Simon

  • Joy Kolonoski

  • David J. Graham

  • Rongmei Zhang

  • John G. Connolly

  • April 24, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Brigham and Women's Hospital
    Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Hematology
    • Pharmacoepidemiology
  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Neurology
    • Clinical Research
  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Hematology
    • Epidemiology
  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Pharmacoepidemiology
    • Neurology
  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Cardiology
    • Clinical Epidemiology

Original Source(s)

Related Content